Broker reconciliation — 2026-09-02 #

Source: every DEGIRO "Transaktionsbestätigung" email in Gmail (sender benachrichtigungen@degiro.de), 2026-01-01 to 2026-09-02, read in full for fills after 2026-06-30. Amounts are DEGIRO's own EUR figures, net of AutoFX and transaction fees. Compared against output/portfolios/graham/*.json as of tag v2026-09-02-pre-reset.

Result #

The ledger was nine fills behind. Three positions it showed as open (AIG, NFLX, PLTR) had been sold; two names it did not know about (RDDT, INTC) were bought. The ledger, the weekly monitor and ten alerts ran on phantom positions for up to eight weeks. All nine fills are now recorded.

2026 transactions (single names and ETF core) #

Deposits ("Zahlungseingang") landed Mar 6, Mar 15, Apr 7 (×2), May 1 (×2), Jul 7, Jul 17, Aug 27 (×3); DEGIRO's notices do not state amounts. No IS3Q, IS3S, YCSH or IBGS purchase exists in 2026: the July ETF-tilt tranche and the "opportunity reserve" were never executed. VWCE accumulation continued (18 shares in 2026 on top of at least 40 from 2025).

2025, for context: at least 46 confirmations from Feb to Dec 2025 (VWCE accumulation plus speculative round-trips in MVST, SLS, NFE, SGBX, ADAP, ON, ADBE, WMT, NVDA, ORCL, UBER, MRVL, O, PBF), all single names closed by 2025-12-22 except SLS. Not reconciled into the ledger; the ledger starts 2026-03-06.

Ledger changes applied #

Realized on the three closes: +EUR 106.63. Realized since the ledger opened (RI.PA, NFLX, AIG, PLTR): +EUR 69.91. Biotech bucket (SLS +USD 537, GANX −EUR 27.09) is outside the ledger.

The book after reconciliation #

Process findings (against CLAUDE.md as reset on 2026-09-02; the June charter was in force at the time and banned all of this too) #

1. RDDT and INTC were bought the way rule-001 says not to buy. Both are attention names in late August; no entry alert existed for either, no red-flag check (rule-007), no good/cheap assessment (rules 003/004), no funding line. RDDT is the playbook's own example of SBC-inflated free cash flow. INTC had been cut from the June sleeve on 2026-06-25 for a negative margin of safety and is now the largest position in the book at 34% of cost, above the rule-006 cap.
2. AIG and NFLX were sold on no signal. Neither a take-profit rung nor a kill condition had fired; both exits funded INTC. Rule-008 allows exits on rungs or fundamentals only. AIG went out at −2.6%; NFLX at +10.3%.
3. PLTR was sold correctly. TP2 at 185 fired on Aug 27; the sale at 185.35 on Aug 31 is the ladder doing its job (rule-008, no-thesis position trimmed mechanically). Only the recording was missed.
4. The NFLX-ADD trigger was acted on (Jul 17, 5 sh at 69.265 with the alert at ≤70), which is the entry-wait mechanism working; but the size (5 sh, EUR 306) was 2-3× the plan's T2 and the Jul 8 add at 76.42 had no trigger at all.
5. Nothing was recorded. Every fill after Jun 30 is missing from the ledger. The alerts, the weekly AIG monitor (which logged an AMBER on Aug 17 and would have run again Sep 7) and the 2026-09-02 state note were all describing a portfolio that no longer existed (rule-002). The ETF tilt and the opportunity reserve, which several alert notes name as their funding source, were never funded.

What is armed now #

• RDDT-DECIDE-UP ≥180 / RDDT-DECIDE-DOWN ≤133 and INTC-DECIDE-UP ≥104 / INTC-DECIDE-DOWN ≤77: placeholders at ±15% from cost. Not stop losses. Each says: write the thesis (good? cheap?) with real rungs, or trim. Post-hoc logs: output/graham/scores/RDDT_execution.md, INTC_execution.md.
• PLTR-BUYZONE ≤70 re-armed as a plain entry-wait (not held).
• AIG, NFLX, PLTR take-profit and add alerts removed (10 keys).
• The weekly monitor will report "NO PLAN FILE" for RDDT and INTC until a plan exists.